Literature DB >> 10612524

Irreversible corneal decompensation in patients treated with topical dorzolamide.

I Adamsons.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10612524     DOI: 10.1016/s0002-9394(99)00349-9

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  8 in total

1.  Choroidal detachment induced by dorzolamide 20 years after cataract surgery.

Authors:  S Davani; B Delbosc; B Royer; J-P Kantelip
Journal:  Br J Ophthalmol       Date:  2002-12       Impact factor: 4.638

2.  Brinzolamide induced reversible corneal decompensation.

Authors:  J C Zhao; T Chen
Journal:  Br J Ophthalmol       Date:  2005-03       Impact factor: 4.638

Review 3.  Topical dorzolamide 2%/timolol 0.5%: a review of its use in the treatment of open-angle glaucoma.

Authors:  D Ormrod; K McClellan
Journal:  Drugs Aging       Date:  2000-12       Impact factor: 3.923

Review 4.  Brinzolamide : a review of its use in the management of primary open-angle glaucoma and ocular hypertension.

Authors:  Risto S Cvetkovic; Caroline M Perry
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 5.  Pediatric Glaucoma: Pharmacotherapeutic Options.

Authors:  Monica Samant; Anagha Medsinge; Ken K Nischal
Journal:  Paediatr Drugs       Date:  2016-06       Impact factor: 3.022

6.  CD147 required for corneal endothelial lactate transport.

Authors:  Shimin Li; Tracy T Nguyen; Joseph A Bonanno
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-06-26       Impact factor: 4.799

7.  Brinzolamide ophthalmic suspension: a review of its pharmacology and use in the treatment of open angle glaucoma and ocular hypertension.

Authors:  Michele Iester
Journal:  Clin Ophthalmol       Date:  2008-09

Review 8.  A Narrative Review of Ocular Surface Disease Related to Anti-Glaucomatous Medications.

Authors:  Xiaoyu Zhou; Xinyue Zhang; Dengming Zhou; Yang Zhao; Xuanchu Duan
Journal:  Ophthalmol Ther       Date:  2022-08-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.